Usefulness of Biomarkers for Predicting Long-Term Mortality in Patients With Diabetes Mellitus and Non–ST-Elevation Acute Coronary Syndromes (A GUSTO IV Substudy)
- 21 November 2005
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (2), 167-172
- https://doi.org/10.1016/j.amjcard.2005.08.036
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Heart-Kidney Interactions in Ischemic SyndromesCirculation, 2004
- N -Terminal Pro–Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery DiseaseCirculation, 2003
- Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndromeJournal of the American College of Cardiology, 2003
- N-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary SyndromesCirculation, 2002
- The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trialThe Lancet, 2001
- Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery DiseaseNew England Journal of Medicine, 2000
- Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy MenCirculation, 2000
- Plasma N-Terminal Pro–Brain Natriuretic Peptide and AdrenomedullinCirculation, 1998
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976